Today, we will study why Eton Pharmaceuticals (ETON) is an attractive pick in 2020.
Company overview
Founded in 2017 with a $20 million financing, Eton Pharmaceuticals is a specialty pharmaceutical company focused mainly on opportunities in the hospital and pediatric settings. The company started trading on the Nasdaq exchange in 2018.
Eton Pharmaceuticals uses the 505((B))(2) regulatory pathway for development of branded products to ensure lower costs as well as lower overall risk profile. This pathway is used to launch proprietary formulations of already-approved molecules to improve on the original qualities of the drug. In